Youtor
Martin Ciernik Corporate Learning Participant Accelerate HMX
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=WHMTGec9vaQ
Martin Ciernik, PharmD, a medical affairs manager at Boehringer Ingelheim, is passionate about the importance of lifelong learning. During his career with Boehringer Ingelheim, he has focused on bridging clinical science with clinical reality and collaborating with clinicians to improve the lives of patients. • In 2021, Boehringer Ingelheim initiated a comprehensive, company-wide plan to change the way clinical development and medical affairs work is done at the pharmaceutical company. The ambitious goal of “One Medicine” is to bring therapies to market more quickly and create new levels of value for patients. A major part of this transformation was the launch of the “University of Medicine Excellence” to build the capabilities of individuals and teams to increase speed and value. • After evaluating multiple educational providers, Boehringer Ingelheim selected Harvard Medical School Corporate Learning to work with the University of Medicine Excellence to create and co-deliver its “Accelerate” executive education program. The Accelerate program aims to empower individuals to grow as leaders and apply their skills to Boehringer Ingelheim, the biopharma industry, and the broader health care sector. Participants explore the main drivers of change in health care and identify implications for the company. Patient centricity and engagement are core to the curriculum. • Harvard Medical School has also created an advanced program, AccelerateEX, which includes in-person program time at HMS’s campus in Boston and the company’s German headquarters in Ingelheim. AccelerateEX participants work on real life challenges from the medicine organization and present their project solutions to executives at the end of the program. Additionally, the University of Medicine Excellence is making HMS’s HMX online medical science courses available to the entire Medicine community at Boehringer Ingelheim. • To learn more about Martin Ciernik and other impact stories, visit https://hms.harvard.edu/departments/o....
#############################
